86
Kulkarni MM, McMaster WR, Kamysz E, Kamysz W, Engman DM, McGwire BS. The
major surface-metalloprotease of the parasitic protozoan,
Leishmania
, protects against
antimicrobial peptide-induced apoptotic killing. Mol Microbiol. 2006; 62(5): 1484-97.
Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Killick-
Kendric R, Peters W, editores. The Leishmaniases in Biology and Medicine. London:
Academic Press; 1987. p. 1-120
Lainson R, Shaw JJ. Leishmaniasis of the New World: taxonomic problems. Brit Med Bull.
1972; 28: 44-48.
Lainson R, Shaw JJ. The role of animals in the epidemiology of South American
leishmaniasis. In: Lumsden WHR, Evans DA, editores. Biology of the Kinetoplastida.
Vol. 2, London and New York: Academic Press; 1979. p. 1-116.
Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological
functions of autophagy. Dev Cell. 2004; 6(4): 463–77.
Lieke T, Nylén S, Eidsmo L, McMaster WR, Mohammadi AM, Khamesipour A, Berg L,
Akuffo H.
Leishmania
surface protein gp63 binds directly to human natural killer cells
and inhibits proliferation. Clin Exp Immunol. 2008; 153(2): 221-30.
Lindoso, JA. Comportamento Oportunista das Leishmanioses/Opportunistic Behavior of
Leishmaniosis. BEPA. 2006; 3(32): 8-12.
Lopez-Velez R, Perez-Molina JA, Guerrero A, Baquero F, Villarrubia J, Escribano L et al.
Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients
coinfected with human immunodeficiency virus and Leishmania in an area of Madrid,
Spain. Am J Trop Med Hyg. 1998; 58(4): 436-43.
Magill AJ, Grögl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by
Leishmania tropica
in veterans of Operation Desert Storm. N Engl J Med. 1993; 328(19):
1383-7.
Majer F, Pavlícková L, Majer P, Hradilek M, Dolejsí E, Hrusková-Heidingsfeldová O,
Pichová I. Structure-based specificity mapping of secreted aspartic proteases of Candida
parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors
and homology modeling. Biol Chem. 2006; 387(9): 1247-54.
Marques N, Cabral S, Sá R, Coelho F, Oliveira J, Saraiva da Cunha JG et al. Visceral
leishmaniasis and HIV infection in the HAART era. Acta Med Port. 2007; 20(4): 291-8.
Martinez-Cajas JL, Wainberg MA. Protease inhibitor resistance in HIV-infected patients:
molecular and clinical perspectives. Antiviral Res. 2007; 76(3): 203-21. Review.
Mastrolorenzo A, Rusconi S, Scozzafava A, Barbaro G, Supuran CT. Inhibitors of HIV-1
protease: current state of the art 10 years after their introduction. From antiretroviral drugs
to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors. Curr
Med Chem. 2007; 14(26): 2734-48. Review.
Matayoshi ED, Wang GT, Krafft GA, Erickson J. Novel fluorogenic substrates for assaying
retroviral proteases by resonance energy transfer. Science. 1990; 247(4945): 954-8.